- Report
- August 2024
- 121 Pages
Europe
From €1348EUR$1,500USD£1,170GBP
- Report
- August 2024
- 121 Pages
Asia Pacific
From €1348EUR$1,500USD£1,170GBP
- Report
- February 2022
- 195 Pages
Global
From €3236EUR$3,600USD£2,809GBP
- Report
- January 2025
- 140 Pages
Global
From €2663EUR$2,963USD£2,312GBP
€3551EUR$3,950USD£3,082GBP
- Report
- December 2024
- 144 Pages
Global
From €2663EUR$2,963USD£2,312GBP
€3551EUR$3,950USD£3,082GBP
- Report
- October 2022
- 205 Pages
Asia Pacific
From €3101EUR$3,450USD£2,692GBP
- Clinical Trials
- March 2025
- 1657 Pages
Global
From €3101EUR$3,450USD£2,692GBP
- Report
- December 2024
- 144 Pages
Global
From €13478EUR$14,995USD£11,700GBP
- Report
- November 2024
- 69 Pages
Global
From €3591EUR$3,995USD£3,117GBP
- Report
- October 2020
- 133 Pages
Global
From €13478EUR$14,995USD£11,700GBP
- Report
- March 2025
- 260 Pages
Middle East
From €2607EUR$2,900USD£2,263GBP
- Report
- March 2025
- 260 Pages
Africa
From €2607EUR$2,900USD£2,263GBP
- Report
- March 2025
- 210 Pages
Latin America
From €2607EUR$2,900USD£2,263GBP
- Report
- March 2025
- 840 Pages
Asia Pacific
From €2607EUR$2,900USD£2,263GBP
- Report
- March 2025
- 980 Pages
Europe
From €2607EUR$2,900USD£2,263GBP
- Report
- March 2025
- 1400 Pages
Global
From €4404EUR$4,900USD£3,823GBP
- Report
- March 2025
- 50 Pages
Kenya
From €539EUR$600USD£468GBP
- Report
- March 2025
- 50 Pages
Nigeria
From €539EUR$600USD£468GBP
- Report
- March 2025
- 50 Pages
Egypt
From €539EUR$600USD£468GBP
From €539EUR$600USD£468GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more